NGL FINECHEM
Back to Balance Sheet
|
NGL FINECHEM Last 5 Year Profit & Loss Account Balance History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit & Loss Account Balance | ₹277 Cr | ₹257 Cr | ₹217 Cr | ₹198 Cr | ₹149 Cr |
What is the latest Profit & Loss Account Balance ratio of NGL FINECHEM ?
| Year | Profit & Loss Account Balance |
|---|---|
| Mar2025 | ₹277 Cr |
| Mar2024 | ₹257 Cr |
| Mar2023 | ₹217 Cr |
| Mar2022 | ₹198 Cr |
| Mar2021 | ₹149 Cr |
How is Profit & Loss Account Balance of NGL FINECHEM Trending?
| Years | Profit & Loss Account Balance | % Change | |
|---|---|---|---|
| Mar2025 | ₹277 Cr | 7.70 | |
| Mar2024 | ₹257 Cr | 18.45 | |
| Mar2023 | ₹217 Cr | 9.77 | |
| Mar2022 | ₹198 Cr | 32.69 | |
| Mar2021 | ₹149 Cr | - | |
Compare Profit & Loss Account Balance of peers of NGL FINECHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NGL FINECHEM | ₹814.4 Cr | 0.5% | -1.6% | -31.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,590.0 Cr | -2% | -6.1% | -6.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,577.0 Cr | -0.8% | -0.8% | 8.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,301.0 Cr | 0% | 2.7% | 11% | Stock Analytics | |
| CIPLA | ₹120,471.0 Cr | -0.6% | -2.6% | 0.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,660.0 Cr | -1.3% | 0.6% | -6.4% | Stock Analytics | |
NGL FINECHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NGL FINECHEM | 0.5% |
-1.6% |
-31.8% |
| SENSEX | -1% |
-1.2% |
7.9% |
You may also like the below Video Courses